Internal Limiting Membrane Peeling for Large Macular Holes

This study has been completed.
Sponsor:
Information provided by:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00190190
First received: September 13, 2005
Last updated: July 16, 2008
Last verified: July 2007

September 13, 2005
July 16, 2008
January 2005
May 2008   (final data collection date for primary outcome measure)
percentage of success (anatomical closing, confirmed by OCT) at third postoperative month, in both groups [ Time Frame: at 3 months ] [ Designated as safety issue: No ]
percentage of success (anatomical closing, confirmed by OCT) at third postoperative month, in both groups
Complete list of historical versions of study NCT00190190 on ClinicalTrials.gov Archive Site
  • Percentage of success according to the effective success of peeling (failure, partial peeling, peeling 360°) in the peeling group of the MLI. [ Time Frame: at 3 months ] [ Designated as safety issue: No ]
  • Gain of ETDRS visual acuity in the third postoperative month [ Time Frame: at 3 months ] [ Designated as safety issue: Yes ]
  • Progression of cataract [ Time Frame: at 3 months ] [ Designated as safety issue: Yes ]
  • Frequency of the complications. [ Time Frame: at 3 months ] [ Designated as safety issue: Yes ]
  • - Percentage of success according to the effective success of peeling (failure, partial peeling, peeling 360°) in the peeling group of the MLI.
  • - Gain of ETDRS visual acuity in the third postoperative month
  • - Progression of cataract
  • - Frequency of the complications.
Not Provided
Not Provided
 
Internal Limiting Membrane Peeling for Large Macular Holes
Comparison of the Success Rate of a Procedure With Peeling of Limiting the Intern of the Retina Versus a Traditional Procedure Without Peeling of Limiting, at Patients Presenting a Macular Hole.

Rational of the study: for macular holes larger than 400 µm the rate of failure is of more than 20%. It is for these eyes that it is necessary to show the benefit of internal limiting membrane (ILM) peeling in term of vision and success rate. In order to test the benefit of this gesture, it is necessary to make a randomized study.

Primary objective: To show that the percentage of success (anatomical closing, confirmed by OCT) at third postoperative month is higher in the ILM peeling group.

Design of the study: Randomized multicentric study, in parallel groups, with individual benefit for the patient.

Tested Hypothesis: The success rate of the surgery of idiopathic macular holes larger than 400 µm is increased by the peeling of the MLI.

Awaited results: To show that the success rate of the surgery of idiopathic macular holes larger than 400 µm is improved by ILM peeling. This category could then have a success rate similar to the small holes. If this difference is not proven, it will remain no justification to continue this procedure which represents little risk but which is not either without consequence.

Rational of the study: for macular holes larger than 400 µm the rate of failure is of more than 20%. It is for these eyes that it is necessary to show the benefit of internal limiting membrane (ILM) peeling in term of vision and success rate. In order to test the benefit of this gesture, it is necessary to make a randomized study.

Primary objective: To show that the percentage of success (anatomical closing, confirmed by OCT) at three postoperative months is higher in the ILM peeling group.

Design of the study: Randomized multicentric study, in parallel groups, with individual benefit for the patient.

Tested Hypothesis: The success rate of the surgery of idiopathic macular holes larger than 400 µm is increased by the peeling of the MLI.

Secondary objectives: - Percentage of success according to the effective success of peeling (failure, partial peeling, peeling 360°) in the peeling group of the MLI. - Gain of ETDRS visual acuity in the third postoperative month.- Progression of cataract - Frequency of the complications.

Number of subjects and duration of the study: 80 patients older than 18 yo , presenting a macular hole > 400 µm, divided into two parallel groups will be included and followed up 3 months. The estimated total duration of the study is 27 months.

Statistical analysis: The percentages of success in the 2 groups will be compared by a Chi ² or Fisher exact test. The test Q of COCHRAN will be used to take into account the ordered character of the categories.

Intermediate Analysis: An intermediate analysis is envisaged. The procedure of adjustment of the risk of Lan and DeMets will be used.

Awaited results: To show that the success rate of the surgery of idiopathic macular holes larger than 400 µm is improved by ILM peeling. This category could then have a success rate similar to the small holes. If this difference is not proven, it will remain no justification to continue this procedure which represents little risk but which is not either without consequence.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Bio-equivalence Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Macular Hole
  • Procedure: With Peeling of Limiting the Intern of the Retina
    With Peeling of Limiting the Intern of the Retina
    Other Name: With Peeling of Limiting the Intern of the Retina
  • Procedure: Internal limiting membrane peeling
    Traditional Procedure Without Peeling of Limiting
    Other Name: Traditional Procedure Without Peeling of Limiting
  • Experimental: 1
    With Peeling of Limiting the Intern of the Retina
    Intervention: Procedure: With Peeling of Limiting the Intern of the Retina
  • Active Comparator: 2
    Traditional Procedure Without Peeling of Limiting
    Intervention: Procedure: Internal limiting membrane peeling
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
80
May 2008
May 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age equal to or higher than 18 years
  • Patient presenting a TM idiopathic of stage 2, 3 or 4
  • Macular hole > 400 µm in diameter
  • Patient having been informed of the objectives and constraints of the study and having signed an informed consent

Exclusion Criteria:

  • Patient age < 18 years.
  • Patient having a strong myopia of the operated eye: correction carried or optimal >6 dioptres
  • Patient MONOPHTHALMIA.
  • Patient pseudophakia presenting an "insufficient" plan capsular CRYTALLINE.
  • Patient presenting a cataract making impossible a good visualization of the bottom of eye.
  • Patient presenting an important opacification capsular.
  • Patient presenting an associated ocular pathology being able to interfere with the operation.
  • Patient presenting a TM already operated of the eye to include
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00190190
P040604, PS040604
No
Yannick VACHER, Department Clinical Research of Developpement
Assistance Publique - Hôpitaux de Paris
Not Provided
Principal Investigator: Ramin TADAYONI, MD Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
July 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP